Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma
Clinical trial NCT05184946 · UNKNOWN
Trial details
- NCT number
- NCT05184946
- Sponsor
- The Second Affiliated Hospital of Shandong First Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-09
- Primary completion
- 2025-10-08
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.